Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Drugs of Today (Barcelona, Spain : 1998)|November 13, 2004
Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depressionXavier RabassedaDrugs of Today (Barcelona, Spain : 1998)|July 16, 2003
Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosingXavier RabassedaDrugs of Today (Barcelona, Spain : 1998)|August 19, 2011
A report from the 164th American Psychiatric Association (May 14-18, 2011 - Honolulu, Hawai'i, U.S.A.)Xavier RabassedaDrugs of Today (Barcelona, Spain : 1998)|February 13, 2003
Frovatriptan: a selective type 1B/1D serotonin receptor agonist for the treatment of migraine headachePatrick Cole, Xavier RabassedaDrugs of Today (Barcelona, Spain : 1998)|December 18, 2004
Quetiapine in bipolar disorder: Increasing evidence of efficacy and tolerabilityPatrick Cole, Xavier RabassedaDrugs of Today (Barcelona, Spain : 1998)|August 6, 2005
Enhanced hypercholesterolemia therapy: the ezetimibe/simvastatin tabletPatrick Cole, Xavier RabassedaDrugs of Today (Barcelona, Spain : 1998)|June 11, 2004
The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic diseasePatrick Cole, Xavier RabassedaDrugs of Today (Barcelona, Spain : 1998)|January 13, 2005
Tegaserod: a serotonin 5-HT4 receptor agonist for treatment of constipation-predominant irritable bowel syndromePatrick Cole, Xavier RabassedaDrugs of Today (Barcelona, Spain : 1998)|May 10, 2003
Esomeprazole: A significant advance beyond omeprazole in the treatment of acid-related diseaseXavier Rabasseda, Patrick ColeDrugs of Today (Barcelona, Spain : 1998)|December 12, 2003
Olmesartan, an AT1-selective antihypertensive agentKim Chilman-Blair, Xavier RabassedaPageof 3